Teva Settles Legal Dispute Over Executive Compensation

In its effort to settle a months-long class action lawsuit alleging that Teva Pharmaceutical's (NYSE: TEVA  ) practices surrounding the disclosure of executive compensation did not meet regulatory guidelines, Teva has agreed to pay plaintiffs' legal and related costs of $1.1 million, as well as $200,000 in "compensation to the plaintiffs," the company announced today.

In addition to the monetary settlement, Teva will begin disclosing individual executive's compensation beginning with its 2013 annual report, expected for release in early 2014. Prior to today's settlement, Teva had reported its top 11 executives' pay only as a group, which Sharon Hannes and Ehud Kamar, the two Teva shareholders who filed the class action suit, said was a violation of U.S. and Israeli rules.

The settlement is subject to approval by the Tel Aviv District Court.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2498643, ~/Articles/ArticleHandler.aspx, 7/30/2014 4:44:11 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement